Bictegravir sodium
1807988-02-8
Shanghai Port
1kg/10kg
2023-08-03
Upadacitinib Hemihydrate,(S)-(+)-1-Boc-3-hydroxypyrrolidine
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
Bictegravir sodium
Other Name:Bictegravir sodium;1807988-02-8;UNII-4L5MP1Y7W7;4L5MP1Y7W7;sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate;sodium (2R,5S,13aR)-7,9-dioxo-10-[(2,4,6-trifluorobenzyl)carbamoyl]-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate;Bictegravir sodium [USAN];Bictegravir sodium (JAN/USAN);CHEMBL3989867;SCHEMBL19991461
CAS No.:1807988-02-8
Molecular Formula:C21H17F3N3NaO5
InChIKeys:WJNFBIVCQMPPJC-FQYDJHLKSA-M
Molecular Weight:471.4
Exact Mass:471.10179942
UNII:4L5MP1Y7W7
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Upadacitinib Hemihydrate,(S)-(+)-1-Boc-3-hydroxypyrrolidine
-
Location:
Honggutan District, Nanchang City, Jiangxi Province
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
50
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2021
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product